# A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients

> **NCT06486662** · PHASE1 · COMPLETED · sponsor: **OM Pharma SA** · enrollment: 41 (actual)

## Conditions studied

- Allergic Asthma

## Interventions

- **DRUG:** OM-85-IN
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06486662
- **Lead sponsor:** OM Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-14
- **Primary completion:** 2025-02-19
- **Final completion:** 2025-02-19
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486662, "A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06486662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*